A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

The correlation between the rise of these appetite-suppressing drugs and the decline in snack sales suggests that as more ...

More patients come forward with stories about the pains they've suffered since beginning Ozempic, joining a growing number of ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Novo Nordisk’s net profit of $3.94bn represents a 21% increase from Q3 2023. Net sales in the quarter jumped by the same ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Catalent's revenue for fiscal first quarter ended Sept. 30 was $1.02 billion, marginally below analysts' estimates of $1.06 ...

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

Obesity could be halved by the end of the decade if there was better access to weight-loss drugs like Ozempic and junk food ...

Endevica Bio has launched a new spin-off company, Abisati, to accelerate its obesity candidate into clinical trials.